People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Other, Investment Vehicle
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| REEP3Prop, LP | — | Other | Series B | $46.0M | $137.8M | 2024 |
| REEP2Prop, LLC | — | Other | Series B | $27.0M | $271.8M | 2022 |
| Oaks2Prop, LLC | — | Other | Series B | $24.0M | $197.8M | 2023 |
| REEP Income Debt Fund II, LP | — | Investment Vehicle | Series B | $20.0M | $108.7M | 2025 |
| 409 William, LLC | — | Other | Series B | $19.5M | $167.3M | 2023 |
| 2701 Bellfort, LP | — | Other | Series B | $16.0M | $121.7M | 2023 |
| 13030 Cape, LP | — | Other | Series A | $14.0M | $108.7M | 2022 |
| 5110 Azalea, LLC | — | Other | Series A | $12.0M | $104.1M | 2022 |
| 9205 Fm78, Llc | — | Other | Series A | $11.0M | $115.3M | 2021 |
| 1800 St Joseph, LLC | — | Other | Series A | $10.1M | $97.6M | 2021 |
| Sa2Prop, Llc | — | Other | Series A | $8.8M | $133.2M | 2017 |
| 16339 Stuebner, LLC | — | Other | Series A | $8.0M | $59.4M | 2022 |
| 7250 West Greens, LLC | — | Other | Series A | $8.0M | $91.4M | 2021 |
| 1720 Crestdale, LLC | — | Other | Series A | $4.9M | $44.3M | 2022 |
| 36 Btr, Lp | — | Other | Seed | $3.0M | $29.4M | 2022 |
| REEP Income Debt Fund I, LP | — | Investment Vehicle | Seed | $3.0M | $15.0M | 2024 |
| ASA2Prop, LP | — | Other | Series B | $275K | $1.3M | 2025 |
Arleen Garza at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Arleen Garza on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jacob Garza | 17 | 19 |
| Michael Guthrie | 3 | 6 |
| Samantha Guthrie | 3 | 3 |
| Rebecca Treanor | 2 | 2 |
| Kris Martinez | 1 | 2 |
| Tu Pham | 1 | 1 |
| Thai Vuu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.